Risdiplam in Presymptomatic Spinal Muscular Atrophy
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (22)
Richard S. Finkel
Center for Experimental Neurotherapeutics, Department of Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN
Laurent Servais
MDUK (Muscular Dystrophy UK) Oxford Neuromuscular Centre and NIHR (National Institute for Health and Care Research) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Dmitry Vlodavets
Russian Children Neuromuscular Center, Veltischev Clinical Pediatrics and Pediatric Surgery Research Institute of Pirogov Russian National Research Medical University, Moscow
Edmar Zanoteli
Department of Neurology, Faculdade de Medicina, Universidade de São Paulo, São Paulo
Maria Mazurkiewicz-Bełdzińska
Department of Developmental Neurology, Chair of Neurology, Medical University of Gdańsk, Gdańsk, Poland
Yuh-Jyh Jong
Aledie Navas-Nazario
Division of Pulmonology, Nemours Children’s Health Orlando, Orlando, FL
Mohammad Al-Muhaizea
Neuroscience Center, King Faisal Specialist Hospital and Research Center–Riyadh, Riyadh, Saudi Arabia
Alexandra P.Q.C. Araujo
Department of Pediatrics, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro
Leslie Nelson
Department of Physical Therapy, University of Texas Southwestern Medical Center, Dallas
Yi Wang
Birgit Jaber
Pharma Development Safety, F. Hoffmann–La Roche, Basel, Switzerland
Ksenija Gorni
Product Development Medical Affairs, Neuroscience and Rare Disease, F. Hoffmann–La Roche, Basel, Switzerland
Heidemarie Kletzl
Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
Laura Palfreeman
Roche Products, Welwyn Garden City, United Kingdom
Michael Rabbia
Genentech, South San Francisco, CA
Dave Summers
Roche Products, Welwyn Garden City, United Kingdom
Eleni Gaki
Roche Products, Welwyn Garden City, United Kingdom
Kathryn R. Wagner
Pharma Development Neurology, F. Hoffmann–La Roche, Basel, Switzerland
Paulo Fontoura
Product Development Medical Affairs, Neuroscience and Rare Disease, F. Hoffmann–La Roche, Basel, Switzerland
Michelle A. Farrar
Department of Neurology, Sydney Children’s Hospital Network, Sydney
Enrico Bertini
Research Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children’s Research Hospital IRCCS, Rome